Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
Not Confirmed
Not Confirmed
24-25 July, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Not Confirmed
Not Confirmed
24-27 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
Industry Trade Show
Not Confirmed
24-25 July, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Industry Trade Show
Not Confirmed
24-27 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
12 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/12/3098209/0/en/Angitia-Biopharmaceuticals-Announces-Topline-Results-from-First-in-Human-Study-of-AGA2115-A-Bispecific-Antibody-for-the-Treatment-of-Osteogenesis-Imperfecta.html
18 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2025/03/18/3044330/0/en/Angitia-Biopharmaceuticals-Presents-Data-from-Phase-1-2-Study-of-AGA111-at-2025-AAOS-Annual-Meeting.html
08 Jan 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/01/08/3006150/0/en/Angitia-Biopharmaceuticals-to-Present-at-the-43rd-Annual-J-P-Morgan-Healthcare-Conference.html
11 Dec 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/12/11/2995375/0/en/Angitia-Biopharmaceuticals-Announces-120-Million-Series-C-Financing.html
10 Dec 2024
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/angitia-raises-120m-series-c-fund-trio-musculoskeletal-trials
ABOUT THIS PAGE